Pages that link to "Q43690649"

The following pages link to Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients (Q43690649):

Displaying 41 items.

• Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652 (Q24672572) (← links)
• QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. (Q24796217) (← links)
• Cardiovascular considerations in antidepressant therapy: an evidence-based review (Q27021843) (← links)
• Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review (Q28076706) (← links)
• An analysis of QTc prolongation with atypical antipsychotic medications and selective serotonin reuptake inhibitors using a large ECG record database (Q30489429) (← links)
• Open channel block of Kv1.5 currents by citalopram (Q33557233) (← links)
• Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease (Q33751924) (← links)
• Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports (Q34016220) (← links)
• Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis (Q34132829) (← links)
• Effects of sertraline on autonomic and cognitive functions in healthy volunteers (Q34190350) (← links)
• Antipsychotic-related QTc prolongation, torsade de pointes and sudden death (Q34730759) (← links)
• Cardiovascular Effects of Selective Serotonin Reuptake Inhibitors and Other Novel Antidepressants (Q35114170) (← links)
• The use of gabapentin for the treatment of postherpetic neuralgia (Q35174228) (← links)
• Safety of antidepressants in the elderly (Q35194349) (← links)
• The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. (Q35236618) (← links)
• Trends in the development of new antidepressants. Is there a light at the end of the tunnel? (Q35743638) (← links)
• Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? (Q35867252) (← links)
• Cardiologic side effects of psychotropic drugs. (Q36077336) (← links)
• Wide spectrum of inhibitory effects of sertraline on cardiac ion channels (Q36358145) (← links)
• Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose (Q36855935) (← links)
• Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly (Q37186658) (← links)
• Neurotransmission in Parkinson's disease: beyond dopamine (Q37668684) (← links)
• A review of SSRIs and SNRIs in neuropathic pain (Q37773988) (← links)
• The Role of Cardiovascular Screening in Headache Patients (Q37834037) (← links)
• Pharmacological management of unipolar depression (Q38099042) (← links)
• Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram (Q38153098) (← links)
• The value of drug and metabolite concentration in blood as a biomarker of psychopharmacological therapy (Q38154910) (← links)
• A comparison of the risk of QT prolongation among SSRIs (Q38164684) (← links)
• One-month serotonin infusion results in a prolonged fall in blood pressure in the deoxycorticosterone acetate (DOCA) salt hypertensive rat. (Q41814079) (← links)
• Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model (Q45840756) (← links)
• Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects. (Q46038779) (← links)
• Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. (Q46150867) (← links)
• Fracture risks of antidepressants (Q46186376) (← links)
• Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers (Q46298114) (← links)
• The influences of depression and venlafaxine use at therapeutic doses on atrial conduction (Q46565089) (← links)
• Orthostatic side effects of clomipramine and moclobemide during treatment for depression (Q46728681) (← links)
• Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic. (Q47134235) (← links)
• Antidepressant up-titration: pharmacological and psychological considerations (Q47305589) (← links)
• Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies (Q48576448) (← links)
• Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. (Q50733150) (← links)
• Optimization of alcohol-assisted dispersive liquid-liquid microextraction by experimental design for the rapid determination of fluoxetine in biological samples (Q51736030) (← links)